Karin M. Gerstin, Ph.D. Patent Agent

Dr. Gerstin is a Patent Agent in the firm’s San Diego office. Dr. Gerstin’s practice focuses on drafting and prosecuting patent applications in the field of biotechnology, including applications relating to nucleic acid and protein sequences, nucleic acid-based assays, cell-based assays, vaccines, antibodies, diagnostic assays, and stem cell biology. Dr. Gerstin also assists counsel with due diligence, freedom-to-operate and patent landscape analyses.

U.S. Patent and Trademark Office

University of San Diego School of Law (J.D.  2013)
University of California, San Francisco (Ph.D.  )
University of California, San Diego (B.A.  )

AAPS Graduate Symposium in Biotechnology, AAPS National Meeting Indianapolis, IN (October, 2000)

Dr. Gerstin specializes in the technical areas of molecular and cellular biology. Dr. Gerstin previously conducted primary scientific research focusing on the role of nucleoside transporters in drug disposition through analysis of the determinants of selectivity and the characterization of the scope of substrate selectivity using molecular biology-based methodologies.


Gerstin et al., Mutation of KCNK5 or Kir3.2 potassium channels in mice does not change minimum alveolar concentration. Anesthesia and Analgesia 96(5):1345-9 (2003).
Gerstin et al., Specificity of human and rat orthologs of the concentrative nucleoside transporter, SPNT. American Journal of Physiology – Renal Physiology 283(2):F344-9 (2002).
Coauthor, Electrophysiological analysis of the substrate selectivity of a sodium-coupled nucleoside transporter (rCNT1) expressed in Xenopus laevis oocytes. Drug Metabolism and Disposition 28(9):1135-40 (2000).
Gerstin et al., Molecular cloning of a Na+-dependent nucleoside transporter from rabbit intestine. Pharmaceutical Research 17(8):904-908 (2000).